ask="4.00"
ask_size="700"
average_daily_volume="23776"
bid="2.62"
bid_size="100"
book_value="-0.23"
change="-0.34"
change_from_200_day_moving_average="-0.86"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-2.69"
change_From_52_week_low="1.00"
change_in_percent="-10.83%"
close="2.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.67"
ebitda="-49.36M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.50"
ex_dividend_date="N/A"
float_shares="9614000"
high="3.01"
high_52_weeks="5.49"
last_trade_date="1/18/2017"
last_trade_price="2.80"
last_trade_size="300"
last_trade_time="3:59pm"
low="2.71"
low_52_weeks="1.80"
market_capitalization="66.02M"
moving_average_200_day="3.66"
moving_average_50_day="2.74"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="2.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.53%"
percent_change_from_50_day_moving_average="+2.24%"
percent_change_from_52_week_high="-49.00%"
percent_change_from_52_week_low="+55.22%"
previous_close="3.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="24.85"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.19"
stock_exchange="NGM"
symbol="ONS"
volume="49254"
weeks_range_52="1.80 - 5.49"
